365 related articles for article (PubMed ID: 21195761)
21. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
22. Lung surfactant as a drug delivery system.
Vermehren C; Frokjaer S; Aurstad T; Hansen J
Int J Pharm; 2006 Jan; 307(1):89-92. PubMed ID: 16310989
[TBL] [Abstract][Full Text] [Related]
23. Clinical perspectives on pulmonary systemic and macromolecular delivery.
Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
[TBL] [Abstract][Full Text] [Related]
24. Dry powder inhalers for pulmonary drug delivery.
Frijlink HW; De Boer AH
Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
[TBL] [Abstract][Full Text] [Related]
25. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
Serrano AG; Pérez-Gil J
Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
[TBL] [Abstract][Full Text] [Related]
26. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway.
Bitonti AJ; Dumont JA
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1106-18. PubMed ID: 16997417
[TBL] [Abstract][Full Text] [Related]
28. Rapidly disintegrating oramucosal drug delivery technologies.
Reddy D; Pillay V; Choonara YE; du Toit LC
Pharm Dev Technol; 2009; 14(6):588-601. PubMed ID: 19883248
[TBL] [Abstract][Full Text] [Related]
29. Applications for site-directed molecular imaging agents coupled with drug delivery potential.
Wang H; Chen X
Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614
[TBL] [Abstract][Full Text] [Related]
30. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
Joshi N
Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
[No Abstract] [Full Text] [Related]
31. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
32. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymeric nanoparticles based drug delivery systems.
Kumari A; Yadav SK; Yadav SC
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):1-18. PubMed ID: 19782542
[TBL] [Abstract][Full Text] [Related]
34. Subcellular drug targeting, pharmacokinetics and bioavailability.
Leucuta SE
J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
[TBL] [Abstract][Full Text] [Related]
35. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
Hadinoto K; Zhu K; Tan RB
Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
[TBL] [Abstract][Full Text] [Related]
36. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
37. Assessment methods of inhaled aerosols: technical aspects and applications.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
[TBL] [Abstract][Full Text] [Related]
38. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans.
Hickey AJ; Garcia-Contreras L
Crit Rev Ther Drug Carrier Syst; 2001; 18(4):387-431. PubMed ID: 11605897
[TBL] [Abstract][Full Text] [Related]
39. Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery.
Li HY; Zhang F
Methods Mol Biol; 2012; 906():295-301. PubMed ID: 22791442
[TBL] [Abstract][Full Text] [Related]
40. Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung.
Casals C
Pediatr Pathol Mol Med; 2001; 20(4):249-68. PubMed ID: 11486733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
